Treating thalassemia major-related iron overload: the role of deferiprone

Over the last 20 years, management for thalassemia major has improved to the point where we predict that patients’ life expectancy will approach that of the normal population. These outcomes result from safer blood transfusions, the availability of three iron chelators, new imaging techniques that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Berdoukas, Vasilios, Farmaki, Kallistheni, Carson, Susan, Wood, John, Coates, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480237/
https://www.ncbi.nlm.nih.gov/pubmed/23112580
http://dx.doi.org/10.2147/JBM.S27400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480237/
https://www.ncbi.nlm.nih.gov/pubmed/23112580
http://dx.doi.org/10.2147/JBM.S27400

Ejemplares similares